| Anticardiolipin cofactor (s) and differential diagnosis of autoimmune disease E Matsuura, Y Igarashi, M Fujimoto, K Ichikawa, T Koike The Lancet 336 (8708), 177-178, 1990 | 911 | 1990 |
| Accelerated atherosclerosis in autoimmune rheumatic diseases Y Shoenfeld, R Gerli, A Doria, E Matsuura, MM Cerinic, N Ronda, LJ Jara, ... Circulation 112 (21), 3337-3347, 2005 | 766 | 2005 |
| Anticardiolipin antibodies recognize beta 2-glycoprotein I structure altered by interacting with an oxygen modified solid phase surface. E Matsuura, Y Igarashi, T Yasuda, DA Triplett, T Koike The Journal of experimental medicine 179 (2), 457-462, 1994 | 713 | 1994 |
| Heterogeneity of anticardiolipin antibodies defined by the anticardiolipin cofactor. E Matsuura, Y Igarashi, M Fujimoto, K Ichikawa, T Suzuki, T Sumida, ... Journal of immunology (Baltimore, Md.: 1950) 148 (12), 3885-3891, 1992 | 419 | 1992 |
| Involvement of β2-glycoprotein I and anticardiolipin antibodies in oxidatively modified low-density lipoprotein uptake by macrophages Y Hasunuma, E Matsuura, Z Makita, T Katahira, S Nishi, T Koike Clinical & Experimental Immunology 107 (3), 569-573, 1997 | 403 | 1997 |
| Pulmonary surfactant protein D in sera and bronchoalveolar lavage fluids. Y Honda, Y Kuroki, E Matsuura, H Nagae, H Takahashi, T Akino, S Abe American journal of respiratory and critical care medicine 152 (6), 1860-1866, 1995 | 389 | 1995 |
| Association of autoantibodies against the phosphatidylserine–prothrombin complex with manifestations of the antiphospholipid syndrome and with the presence of lupus anticoagulant T Atsumi, M Ieko, ML Bertolaccini, K Ichikawa, A Tsutsumi, E Matsuura, ... Arthritis & Rheumatism: Official Journal of the American College of …, 2000 | 370 | 2000 |
| The role of the tissue factor pathway in the hypercoagulable state in patients with the antiphospholipid syndrome O Amengual, T Atsumi, MA Khamashta, GRV Hughes Thrombosis and haemostasis 79 (02), 276-281, 1998 | 346 | 1998 |
| A role for interleukin-2 trans-presentation in dendritic cell–mediated T cell activation in humans, as revealed by daclizumab therapy SC Wuest, JH Edwan, JF Martin, S Han, JSA Perry, CM Cartagena, ... Nature medicine 17 (5), 604-609, 2011 | 313 | 2011 |
| Case-control study of the frequency of thrombophilic disorders in couples with late foetal loss and no thrombotic antecedent JC Gris, I Quéré, F Monpeyrou, E Mercier, S Ripart-Neveu, ML Tailland, ... Thrombosis and haemostasis 81 (06), 891-899, 1999 | 302 | 1999 |
| Oxidation of LDL and its clinical implication E Matsuura, GRV Hughes, MA Khamashta Autoimmunity reviews 7 (7), 558-566, 2008 | 293 | 2008 |
| Oxidative modification of low-density lipoprotein and immune regulation of atherosclerosis E Matsuura, K Kobayashi, M Tabuchi, LR Lopez Progress in lipid research 45 (6), 466-486, 2006 | 270 | 2006 |
| Circulating oxidized LDL forms complexes with β2-glycoprotein I: implication as an atherogenic autoantigen K Kobayashi, M Kishi, T Atsumi, ML Bertolaccini, H Makino, N Sakairi, ... Journal of lipid research 44 (4), 716-726, 2003 | 269 | 2003 |
| Antibodies to β2‐glycoprotein I and clinical manifestations in patients with systemic lupus erythematosus A Tsutsumi, E Matsuura, K Ichikawa, A Fujisaku, M Mukai, S Kobayashi, ... Arthritis & Rheumatism: Official Journal of the American College of …, 1996 | 269 | 1996 |
| Chemical xenobiotics and mitochondrial autoantigens in primary biliary cirrhosis: identification of antibodies against a common environmental, cosmetic, and food additive, 2 … K Amano, PSC Leung, R Rieger, C Quan, X Wang, J Marik, YF Suen, ... The Journal of Immunology 174 (9), 5874-5883, 2005 | 227 | 2005 |
| Anticardiolipin antibodies in NZW x BXSB F1 mice. A model of antiphospholipid syndrome. Y Hashimoto, M Kawamura, K Ichikawa, T Suzuki, T Sumida, S Yoshida, ... Journal of immunology (Baltimore, Md.: 1950) 149 (3), 1063-1068, 1992 | 215 | 1992 |
| Is atherosclerosis an autoimmune disease? E Matsuura, F Atzeni, P Sarzi-Puttini, M Turiel, LR Lopez, ... BMC medicine 12, 1-5, 2014 | 200 | 2014 |
| Are anti–oxidized low-density lipoprotein antibodies pathogenic or protective? Y Shoenfeld, R Wu, LD Dearing, E Matsuura Circulation 110 (17), 2552-2558, 2004 | 199 | 2004 |
| A specific ligand for β2-glycoprotein I mediates autoantibody-dependent uptake of oxidized low density lipoprotein by macrophages K Kobayashi, E Matsuura, Q Liu, J Furukawa, K Kaihara, J Inagaki, ... Journal of lipid research 42 (5), 697-709, 2001 | 189 | 2001 |
| Antiphospholipid syndrome: diagnostic aspects of lupus anticoagulants J Arnout Thrombosis and haemostasis 86 (07), 83-91, 2001 | 182 | 2001 |
Yehuda ShoenfeldСанкт-Петербургский государственный университет在 spbu.ru 的电子邮件经过验证
